TVTI logo
Communities & Collections
All Collections
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register.Have you forgotten your password?
  1. TVTI Library
  2. Browse by Author

Browsing by Author "Sukumar Sakamuri"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Thumbnail Image
    Item
    Pharmacophore-Based Discovery of Substituted Pyridines as Novel Dopamine Transporter Inhibitors
    (2012-11-08) Istvan J. Enyedy; Sukumar Sakamuri; Wahiduz A. Zaman; Kenneth M. Johnsonb; Shaomeng Wanga
    Abnormal dopamine signaling in brain has been implicated in several conditions such as cocaine abuse, Parkinson’s disease and depression. Potent and selective dopamine transporter inhibitors may be useful as pharmacological tools and therapeutic agents. Simple substituted pyridines were discovered as novel dopamine transporter (DAT) inhibitors through pharmacophore- based 3D-database search. The most potent compound 18 has a Ki value of 79 nM in inhibition of WIN35,248 binding to dopamine transporter and 255 nM in inhibition of dopamine reuptake, respectively, as potent as cocaine. Preliminary structure– activity relationship studies show that the geometry and the nature of the substituents on the pyridine ring determine the inhibitory activity and selectivity toward the three monoamine transporters. The substituted pyridines described herein represent a class of novel DAT inhibitors with simple chemical structures and their discovery provides additional insights into the binding site of DAT. # 2002 Elsevier Science Ltd. All rights reserved.
  • Thumbnail Image
    Item
    Pharmacophore-Based Discovery of Substituted Pyridines as Novel Dopamine Transporter Inhibitors
    (2012-11-21) Istvan J. Enyedy; Sukumar Sakamuri; Wahiduz A. Zaman; Kenneth M. Johnsonb; Shaomeng Wanga
    Abnormal dopamine signaling in brain has been implicated in several conditions such as cocaine abuse, Parkinson’s disease and depression. Potent and selective dopamine transporter inhibitors may be useful as pharmacological tools and therapeutic agents. Simple substituted pyridines were discovered as novel dopamine transporter (DAT) inhibitors through pharmacophore- based 3D-database search. The most potent compound 18 has a Ki value of 79 nM in inhibition of WIN35,248 binding to dopamine transporter and 255 nM in inhibition of dopamine reuptake, respectively, as potent as cocaine. Preliminary structure– activity relationship studies show that the geometry and the nature of the substituents on the pyridine ring determine the inhibitory activity and selectivity toward the three monoamine transporters. The substituted pyridines described herein represent a class of novel DAT inhibitors with simple chemical structures and their discovery provides additional insights into the binding site of DAT. # 2002 Elsevier Science Ltd. All rights reserved

TVTI Home page copyright © 2016-2026

P.O. Box: 190310

Tel: +251-116-464455

  • Info Email
  • ICT Email
  • PR Email
  • Registrar Email